BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 20507346)

  • 1. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes.
    Stratakis CA; Tichomirowa MA; Boikos S; Azevedo MF; Lodish M; Martari M; Verma S; Daly AF; Raygada M; Keil MF; Papademetriou J; Drori-Herishanu L; Horvath A; Tsang KM; Nesterova M; Franklin S; Vanbellinghen JF; Bours V; Salvatori R; Beckers A
    Clin Genet; 2010 Nov; 78(5):457-63. PubMed ID: 20507346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
    Igreja S; Chahal HS; Akker SA; Gueorguiev M; Popovic V; Damjanovic S; Burman P; Wass JA; Quinton R; Grossman AB; Korbonits M
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):259-64. PubMed ID: 18710468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for genetic causes of growth hormone hypersecretion.
    Rostomyan L; Beckers A
    Growth Horm IGF Res; 2016; 30-31():52-57. PubMed ID: 27756606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of pituitary adenomas.
    Gadelha MR; Trivellin G; Hernández Ramírez LC; Korbonits M
    Front Horm Res; 2013; 41():111-40. PubMed ID: 23652674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update.
    Karhu A; Aaltonen LA
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R73-9. PubMed ID: 17613551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.
    Cuny T; Pertuit M; Sahnoun-Fathallah M; Daly A; Occhi G; Odou MF; Tabarin A; Nunes ML; Delemer B; Rohmer V; Desailloud R; Kerlan V; Chabre O; Sadoul JL; Cogne M; Caron P; Cortet-Rudelli C; Lienhardt A; Raingeard I; Guedj AM; Brue T; Beckers A; Weryha G; Enjalbert A; Barlier A
    Eur J Endocrinol; 2013 Apr; 168(4):533-41. PubMed ID: 23321498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial pituitary tumor syndromes.
    Elston MS; McDonald KL; Clifton-Bligh RJ; Robinson BG
    Nat Rev Endocrinol; 2009 Aug; 5(8):453-61. PubMed ID: 19564887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial pituitary tumors.
    Alband N; Korbonits M
    Handb Clin Neurol; 2014; 124():339-60. PubMed ID: 25248598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three Novel MEN1 Variants in AIP-Negative Familial Isolated Pituitary Adenoma Patients.
    Yarman S; Tuncer FN; Serbest E
    Pathobiology; 2019; 86(2-3):128-134. PubMed ID: 30630164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
    Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GH-secreting pituitary adenomas infrequently contain inactivating mutations of PRKAR1A and LOH of 17q23-24.
    Yamasaki H; Mizusawa N; Nagahiro S; Yamada S; Sano T; Itakura M; Yoshimoto K
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):464-70. PubMed ID: 12641630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function.
    Lindberg D; Akerström G; Westin G
    Neoplasia; 2007 Jul; 9(7):533-5. PubMed ID: 17710155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia.
    Occhi G; Trivellin G; Ceccato F; De Lazzari P; Giorgi G; Demattè S; Grimaldi F; Castello R; Davì MV; Arnaldi G; Salviati L; Opocher G; Mantero F; Scaroni C
    Eur J Endocrinol; 2010 Sep; 163(3):369-76. PubMed ID: 20530095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain.
    Belar O; De La Hoz C; Pérez-Nanclares G; Castaño L; Gaztambide S;
    Clin Endocrinol (Oxf); 2012 May; 76(5):719-24. PubMed ID: 22026581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of inhibitory guanine nucleotide binding protein alpha (GNAI) loci in young and familial pituitary adenomas.
    Demir H; Donner I; Kivipelto L; Kuismin O; Schalin-Jäntti C; De Menis E; Karhu A
    PLoS One; 2014; 9(10):e109897. PubMed ID: 25291362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone-secreting tumors: genetic aspects and data from animal models.
    Lytras A; Tolis G
    Neuroendocrinology; 2006; 83(3-4):166-78. PubMed ID: 17047380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial isolated pituitary adenomas: an emerging clinical entity.
    Martucci F; Trivellin G; Korbonits M
    J Endocrinol Invest; 2012 Dec; 35(11):1003-14. PubMed ID: 23310926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric growth hormone and prolactin-secreting tumor associated with an
    Alexandre MI; Faria CC; Gomes A; Bugalho MJ
    J Pediatr Endocrinol Metab; 2023 Feb; 36(2):199-202. PubMed ID: 36597712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.
    Tichomirowa MA; Lee M; Barlier A; Daly AF; Marinoni I; Jaffrain-Rea ML; Naves LA; Rodien P; Rohmer V; Faucz FR; Caron P; Estour B; Lecomte P; Borson-Chazot F; Penfornis A; Yaneva M; Guitelman M; Castermans E; Verhaege C; Wémeau JL; Tabarin A; Fajardo Montañana C; Delemer B; Kerlan V; Sadoul JL; Cortet Rudelli C; Archambeaud F; Zacharieva S; Theodoropoulou M; Brue T; Enjalbert A; Bours V; Pellegata NS; Beckers A
    Endocr Relat Cancer; 2012 Jun; 19(3):233-41. PubMed ID: 22291433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.